Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Ryusaku Matsumoto, Masaaki Yamamoto, Genzo Iguchi, Shin Urai, Hidenori Fukuoka, Wataru Ogawa, Kentaro Suda, Hiroki Shichi, Keitaro Kanie, Yutaka Takahashi, Hironori Bando, Yasunori Fujita
Publikováno v:
Cancer Immunology, Immunotherapy
Background Immune checkpoint inhibitors (ICIs) as a cancer immunotherapy have emerged as a treatment for multiple advanced cancer types. Because of enhanced immune responses, immune-related adverse events (irAEs), including endocrinopathies such as h
Autor:
Yoshikazu Takahashi, Hidekazu Shirota, Takashi Yoshioka, Takuhiro Yamaguchi, Kota Ouchi, Michio Kuroki, Shin Takahashi, Masahiro Takahashi, Masaki Tanaka, Masanobu Takahashi, Chikashi Ishioka, Yasuhiro Sakamoto, Hideki Shimodaira, Hiroo Imai, Satoshi Kato, Keigo Komine, Kazunori Otsuka, Hiroyuki Shibata, Hisatsugu Ohori, Hiroaki Yamaguchi, Yasushi Tsuji
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The current study aimed to determine the efficacy of trifluridine/tipiracil for elderly patients with advanced colorectal cancer. Methods This single-arm, open-label, multicenter, phase II study included elderly patients aged 65 years or more
Autor:
Luca Nicosia, Germana Lissidini, Manuela Sargenti, Anna Carla Bozzini, Gabriel Farante, José Vila, Chiara Oriecuia, Eleonora Pagan, Vincenzo Bagnardi, Matteo Lazzeroni, Filippo Pesapane, Claudia Sangalli, Viviana Galimberti, Enrico Cassano, Paolo Veronesi
Publikováno v:
BREAST CANCER RESEARCH AND TREATMENT
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Purpose To present an overview of the management of male patients with Ductal Carcinoma In Situ of the breast (male DCIS). Methods We retrospectively studied all male patients with a diagnosis of pure DCIS from January 1999 to December 2018: 20 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84bbd34cb15b26ed5839006aa50f72e
https://hdl.handle.net/10281/398262
https://hdl.handle.net/10281/398262
Autor:
M.T. Huizing, Stephen Chan, Stefania Russo, Gail S. Wright, Joyce Steinberg, Andrew M Wardley, Ron Bose, Robyn R. Young, A. Jo Chien, Iulia Cristina Tudor, Andrea Rocca, Lowell L. Hart, Javier Cortes, Kathy D. Miller, Hope S. Rugo, Marie-Pascale Graas, Louise Provencher, Patrick Neven, Jennifer Sugg, Ian E. Krop, David Cameron, Vandana G. Abramson
Publikováno v:
Wardley, A, Cortes, J, Provencher, L, Miller, K, Chien, A J, Rugo, H S, Steinberg, J, Sugg, J, Tudor, I C, Huizing, M, Young, R, Abramson, V, Bose, R, Hart, L, Chan, S, Cameron, D, Wright, G S, Graas, M, Neven, P, Rocca, A, Russo, S & Krop, I E 2021, ' The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer ', Breast cancer research and treatment . https://doi.org/10.1007/s10549-021-06109-7
Breast Cancer Research and Treatment
Scientia
Breast cancer research and treatment
Breast Cancer Research and Treatment
Scientia
Breast cancer research and treatment
Purpose Androgen receptor (AR) expression occurs in up to 86% of human epidermal growth factor receptor 2-positive (HER2+) breast cancers. In vitro, AR inhibitors enhance antitumor activity of trastuzumab, an anti-HER2 antibody, in trastuzumab-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98cdcc0d199475dcadec98b642506659
https://lirias.kuleuven.be/handle/20.500.12942/705321
https://lirias.kuleuven.be/handle/20.500.12942/705321
Autor:
Martin J. van den Bent, Katerina Bakunina, Jacoline E C Bromberg, Linda Dirven, Samar Issa, Jeanette K. Doorduijn, Matthijs van der Meulen
Publikováno v:
Journal of Neuro-Oncology, 152(2), 357-362. Kluwer Academic
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Introduction To assess the value of the Mini-Mental State Examination (MMSE)-score at baseline in predicting survival in adult primary central nervous system lymphoma (PCNSL) patients. Methods In the HOVON 105/ ALLG NHL 24 phase III study patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7bd8dbbae5896422024956ad26b38f
https://hdl.handle.net/1887/3251117
https://hdl.handle.net/1887/3251117
Autor:
T. Jeroen N. Hiltermann, Jiacong Wei, Arja ter Elst, Pei Meng, Anthonie J. van der Wekken, Lennart Johansson, Mohamed Z. Alimohamed, Harry J.M. Groen, M. M. Terpstra, Anke van Rijk, Menno Tamminga, Klaas Kok, Rolof P G Gijtenbeek, Anke van den Berg, John W. G. van Putten, Jos A. Stigt, Frank J. G. Scherpen
Publikováno v:
Targeted Oncology
Targeted oncology. SPRINGER
Targeted oncology. SPRINGER
Background The clinical relevance of epidermal growth factor receptor (EGFR) copy number gain in patients with EGFR mutated advanced non-small cell lung cancer on first-line tyrosine kinase inhibitor treatment has not been fully elucidated. Objective
Autor:
Poodt, Ingrid G. M., Schipper, Robert-Jan, de Greef, Bianca T. A., Vugts, Guusje, Maaskant-Braat, Adriana J. G., Jansen, Frits H., Wyndaele, Dirk N. J., Voogd, Adri C., Nieuwenhuijzen, Grard A. P., Roumen, R. M. H., Luiten, E. J. T., Rutgers, E. J. T., Vrancken-Peeters, M. T. F. D., Bessems, M., Klaase, J. M., Muller, S., Francken, A. B., Van Dalen, T., Koopal, S. A., Vissers, Y. L. J., Smidt, M. L., Merkus, J. W. S., Contant, C. M. E., Veldman, P. H., Linthorst-Niers, E. M. H., van der Sijp, J. R., Guicherit, O. R., Koppert, L. B., Bosch, A. M., Strobbe, L. J. A., Schlooz-Vries, M. S., Arntz, I. E., van Essen, J. A., de Waard, J. W. D., Vrouenraets, B. C., van Ooijen, B., Smidt, Marjolein
Publikováno v:
Breast Cancer Research and Treatment, 175(2), 419-428. SPRINGER
Breast Cancer Research and Treatment, 175, 2, pp. 419-428
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 175(2), 419-428. Springer, Cham
Breast Cancer Research and Treatment, 175(2), 419-428. Springer New York
Breast Cancer Research and Treatment, 175, 419-428
Breast Cancer Research and Treatment, 175, 2, pp. 419-428
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 175(2), 419-428. Springer, Cham
Breast Cancer Research and Treatment, 175(2), 419-428. Springer New York
Breast Cancer Research and Treatment, 175, 419-428
Purpose In patients with ipsilateral breast tumor recurrence (IBTR), the detection of distant disease determines whether the intention of the treatment is curative or palliative. Therefore, adequate preoperative staging is imperative for optimal trea
Autor:
Agustí Barnadas, Silvia M. Vidal, Margarita Majem, Leticia Alserawan, Mariona Riudavets, Carlos Zamora, Jorgina Serra, Andrés Barba, Javier Gavira, Pablo Gallardo, M. Angels Ortiz, Georgia Anguera, Lidia Perea, Ivana Sullivan
Publikováno v:
CANCER IMMUNOLOGY IMMUNOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background Anti-PD-(L)1 blocking agents can induce immune-related adverse events (irAEs), which can compromise treatment continuation. Since circulating leukocyte-platelet (PLT) complexes contribute to inflammatory and autoimmune diseases, we aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e09d11d6e57947dc938268b24327bc5
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5108
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5108
Publikováno v:
Breast Cancer Research and Treatment
Purpose As demand for genetic testing grows and a wide range of health care professionals (HCPs) are potentially involved in discussions about testing and delivering results, we developed an educational package to help HCPs with these conversations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0d1814995e45176b91e73a7bcdc719
http://sro.sussex.ac.uk/id/eprint/93279/1/Shilling2020_Article_UsingPatientPerspectivesToInfo.pdf
http://sro.sussex.ac.uk/id/eprint/93279/1/Shilling2020_Article_UsingPatientPerspectivesToInfo.pdf
Autor:
C. A. R. Lok, W.J. van Driel, J. O.A.M. van Baal, E. S. Jordanova, K.K. Van de Vijver, F. C. Amant, Hugo M. Horlings
Publikováno v:
Virchows Archiv, 477(4), 535-544. Springer Verlag
van Baal, J O A M, Lok, C A R, Jordanova, E S, Horlings, H, van Driel, W J, Amant, F C & Van de Vijver, K K 2020, ' The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy ', Virchows Archiv, vol. 477, no. 4, pp. 535-544 . https://doi.org/10.1007/s00428-020-02795-8
van Baal, J O A M, Lok, C A R, Jordanova, E S, Horlings, H, van Driel, W J, Amant, F C & Van de Vijver, K K 2020, ' The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy ', Virchows Archiv, vol. 477, no. 4, pp. 535-544 . https://doi.org/10.1007/s00428-020-02795-8
Peritoneal metastases of high-grade serous ovarian cancer (HGSOC) are small-sized deposits with superficial growth toward the peritoneal cavity. It is unknown whether integrity of the peritoneal elastic lamina (PEL) correlates with the peritoneal tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c318cab177c23d2511b9c545025768e
https://lirias.kuleuven.be/handle/123456789/667106
https://lirias.kuleuven.be/handle/123456789/667106